Literature DB >> 1518345

Auditory performance of children with cochlear ossification and partial implant insertion.

J L Kemink1, S Zimmerman-Phillips, P R Kileny, J B Firszt, M A Novak.   

Abstract

The management of the profoundly deaf child with a cochlear implant poses a special challenge, particularly when total ossification of the cochlea is present. In this setting, insertion of an electrode array into a child's cochlea is often difficult. Our experience supports the feasibility of partial insertion of a multichannel implant into the basal turn of an ossified cochlea. Five children with ossified cochleae who had undergone partial implantation of a multichannel electrode were compared with the performance of matched controls who had full insertion of multichannel implants. No dramatic differences were detected during a 6- to 18-month follow-up period on selected test measures. These preliminary results suggest that active electrode number may exert a limited effect on performance with a cochlear implant. Drilling out the basal turn of an ossified cochlea in conjunction with partial insertion of a multichannel implant appears to be an acceptable surgical and rehabilitational alternative for placement of a cochlear implant prosthesis in children with complete cochlear ossification.

Entities:  

Mesh:

Year:  1992        PMID: 1518345     DOI: 10.1288/00005537-199209000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Cochlear implantation in ossified cochlea-Merf experience.

Authors:  M Kameswaran; R S A Kumar; S Murali; K Natarajan; V Krishnan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2005-10

Review 2.  Indications and contraindications of auditory brainstem implants: systematic review and illustrative cases.

Authors:  Paul Merkus; Fillipo Di Lella; Giuseppe Di Trapani; Enrico Pasanisi; Milo A Beltrame; Diego Zanetti; Maurizio Negri; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-13       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.